Stoneridge, Inc.
NYSE:SRIAuto - Parts
+$0.18 today
- Market cap
- $142.76M
- Beta
- 1.85
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$4.06
Volume 0.14M
Average 0.21M
SRI Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Stoneridge, Inc.NYSE: SRI
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was -$88.35M, compared with -$107.89M a year earlier.
Context
- Accumulated OCI amounted to 17.2% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
- Accumulated OCI grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +18.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (89.1M) USD
- Year-over-year change
- +27.0%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (89.1M) | +27.0% |
| FY2024 | 2024-12-31 | (122.01M) | -31.5% |
| FY2023 | 2023-12-31 | (92.79M) | +10.0% |
| FY2022 | 2022-12-31 | (103.14M) | -6.3% |
| FY2021 | 2021-12-31 | (97.02M) | — |
Accumulated OCI vs competitors
How SRI compares with its peers on the latest reported figures
- Peers report in different currencies, so Accumulated OCI is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +18.1% is the 3rd highest of 6, against a peer median of +6.2%.
- Accumulated OCI amounts to 17.2% of total assets for SRI, versus a peer median of 0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CN¥15.54M CNY | -67.1% | +21.2% | 0.2% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | -$1.23M USD | +58.6% | — | 0.5% | |
AIIORobo.ai Inc. | Jun 2025 | -$4.35M USD | +6.2% | — | 12.4% |
| May 2026 | -$6.1M USD | +19.3% | — | 0.3% | |
| Feb 2026 | -$14.09M USD | — | — | 3.5% | |
| Mar 2026 | -$23.26M USD | -1197.5% | — | 0.9% | |
| Mar 2026 | -$88.35M USD | +18.1% | — | 17.2% | |
| Peer median (excluding SRI) | — | +6.2% | +21.2% | 0.5% | |
Competitors are the stored peer set for SRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 85.55M | 54.8M | 40.84M | 71.83M | 66.25M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 150.39M | 158.16M | 166.55M | 137.77M | 131.43M |
| Inventory | 138.12M | 152.58M | 187.76M | 151.34M | 132.67M |
| Other Current Assets | 18.47M | 44.02M | 34.25M | 26.58M | 31.51M |
| Total Current Assets | 410.82M | 409.55M | 429.39M | 387.51M | 361.87M |
| Property, Plant & Equipment (Net) | 126.24M | 118.41M | 120.92M | 107.72M | 91.44M |
| Goodwill | 36.39M | 34.23M | 35.3M | 33.09M | 37.59M |
| Intangible Assets | 49.86M | 45.51M | 47.31M | 39.68M | 37.97M |
| Long-term Investments | 42.08M | 44.42M | 8.82M | 53.56M | 22.32M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 38.16M | 0 | 0 |
| Total Non-current Assets | 254.58M | 242.55M | 250.51M | 234.04M | 189.32M |
| Total Assets | 665.4M | 652.11M | 679.9M | 621.56M | 551.19M |
| Account Payables | 97.68M | 110.2M | 111.93M | 83.48M | 82.24M |
| Short-term Debt | 5.25M | 1.45M | 2.11M | 3.99M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 18.72M | 19.02M | 14.38M | 41.33M | 25.77M |
| Total Current Liabilities | 173.07M | 177.69M | 178.24M | 149.97M | 157.56M |
| Long-term Debt | 163.96M | 167.8M | 189.35M | 201.58M | 180.94M |
| Deferred Tax Liabilities | 10.71M | 8.5M | 7.22M | 5.32M | 9.97M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 6.81M | 6.58M | 9.69M | 12.94M | 13.92M |
| Total Non-current Liabilities | 196.38M | 193.47M | 213.94M | 226.32M | 213.85M |
| Total Liabilities | 369.45M | 371.16M | 392.18M | 376.3M | 371.41M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 215.75M | 201.69M | 196.51M | 179.99M | 77.15M |
| Accumulated OCI | (97.02M) | (103.14M) | (92.79M) | (122.01M) | (89.1M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 295.95M | 280.94M | 287.72M | 245.26M | 179.78M |
| Total Debt | 184.12M | 179.85M | 203.01M | 212.05M | 189.96M |
| Net Debt | 98.57M | 125.05M | 162.17M | 140.22M | 123.7M |
Stoneridge, Inc.
NYSE:SRI
Intrinsic Alpha fair value
Locked
Current Price
$5.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.